Friday, 9 October 2026European Markets

GOLDEN OCEAN GROUP And STRONGPOINT Have A High Dividend Yield And Return On Equity In The Industrials Sector.

Loading stream...

(VIANEWS) - GOLDEN OCEAN GROUP (GOGL.OL) is among this list of stock assets with the highest dividend rate and return on equity on the Industrials sector.

Financial Asset Price Forward Dividend Yield Return on Equity
GOLDEN OCEAN GROUP (GOGL.OL) kr104.60 15.38% 24.02%
STRONGPOINT (STRO.OL) kr25.80 3.9% 5.13%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. GOLDEN OCEAN GROUP (GOGL.OL)

15.38% Forward Dividend Yield and 24.02% Return On Equity

Golden Ocean Group Limited, a shipping company, owns and operates a fleet of dry bulk vessels comprising Newcastlemax, Capesize, Panamax, and Ultramax vessels worldwide. It owns and operates dry bulk vessels in the spot and time charter markets. The company transports bulk commodities, such as ores, coal, grains, and fertilizers. As of March 23, 2022, it owned a fleet of 81 dry bulk vessels. Golden Ocean Group Limited is based in Hamilton, Bermuda.

Earnings Per Share

As for profitability, GOLDEN OCEAN GROUP has a trailing twelve months EPS of kr24.5.

PE Ratio

GOLDEN OCEAN GROUP has a trailing twelve months price to earnings ratio of 4.27. Meaning, the purchaser of the share is investing kr4.27 for every norwegian krone of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 24.02%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

GOLDEN OCEAN GROUP's EBITDA is 30.22.

Revenue Growth

Year-on-year quarterly revenue growth declined by 33.5%, now sitting on 1.11B for the twelve trailing months.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Feb 27, 2023, the estimated forward annual dividend rate is 16.36 and the estimated forward annual dividend yield is 15.38%.

Moving Average

GOLDEN OCEAN GROUP's worth is way higher than its 50-day moving average of kr94.46 and above its 200-day moving average of kr98.95.

More news about GOLDEN OCEAN GROUP.

2. STRONGPOINT (STRO.OL)

3.9% Forward Dividend Yield and 5.13% Return On Equity

StrongPoint ASA develops and sells technology solutions for e-commerce and store operations in Norway, Sweden, and internationally. It offers various retail solutions, including click and collect, cash management, select and collect, self-service, and electronic shelf labelling solutions, as well as retail management software and other solutions; hardware products; and consultative services. The company sells retail solutions through third-party suppliers. It has a strategic partnership with Halodi Robotics to develop an in-store grocery retail robotics solution. The company was formerly known as PSI Group ASA and changed its name to StrongPoint ASA in September 2015. StrongPoint ASA is headquartered in Rælingen, Norway.

Earnings Per Share

As for profitability, STRONGPOINT has a trailing twelve months EPS of kr2.14.

PE Ratio

STRONGPOINT has a trailing twelve months price to earnings ratio of 12.03. Meaning, the purchaser of the share is investing kr12.03 for every norwegian krone of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.13%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 76.1%, now sitting on 1.25B for the twelve trailing months.

Volume

Today's last reported volume for STRONGPOINT is 8055 which is 69.1% below its average volume of 26074.

Moving Average

STRONGPOINT's worth is way above its 50-day moving average of kr22.79 and way higher than its 200-day moving average of kr20.20.

More news about STRONGPOINT.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,362 source documents archived
Query this data → isubstrate.com